Lambda Therapeutics Research Ltd (LTRL)
Ahmedabad, India
NCT Number: NCT02218528
The study is designed to determine the extent to which a plant-based ingredient is able to modulate blood glucose response when administered with a meal.
Looking for future studies?
Notify Me18 year–50 year
All sexes
Interventional
Not applicable
Ahmedabad, India
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 120 minutes
Time frame: 180 minutes
Time frame: 120 minutes
Time frame: 180 minutes
Time frame: 10 hours
GE50% (time to empty 50% of the gastric content) will be determined with paracetamol
Time frame: 120 minutes
peak plasma glucose
Time frame: 120 minutes
peak plasma glucose - baseline plasma glucose
Time frame: 120 minutes
peak time plasma glucose
Unilever R&D
Industry
An Exploratory Study of a Plant-based Ingredient for Reducing the Post-prandial Blood Glucose Response in Healthy Indian Adults, When Administered With a Meal
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06975319
Healthy, Immunisation Against Streptococcus Pneumoniae
Ghent, Belgium
View Trial DetailsNCT06945419
Body Weight, Body Weight Changes
Daytona Beach, Florida, United States
View Trial DetailsNCT05533372
Arthritis, Arthritis, Rheumatoid
Lenexa, Kansas, United States
View Trial DetailsNCT06916078
Digestive System Diseases, Healthy
Miami, Florida, United States
View Trial Details